Clinical trial · Observational
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
Validation of a Serum Marker Panel for Early Detection of Breast Cancer in High-Risk Women
NCT00897416CI-TRIAL-00004095completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Collecting and storing samples of blood and studying them in the laboratory may help doctors learn more about changes that may occur in DNA and identify biomarkers related to cancer. PURPOSE: This laboratory study is examining biomarkers in women with a high risk or average risk of breast cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| laboratory biomarker analysis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Biomarker evaluation for the early detection of breast cancer to improve outcomes for women at risk for breast cancer
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 25 Years
Show eligibility criteria text
DISEASE CHARACTERISTICS: * Planning to undergo outpatient annual mammogram or biopsy AND meets 1 of the following criteria: * High risk for breast cancer * High risk with newly-diagnosed\* breast cancer * Average risk for breast cancer * Average risk with newly-diagnosed\* breast cancer * Benign breast disease NOTE: \* Diagnosed at time of study enrollment * No other breast cancer diagnosis within the past year * Hormone receptor status: * Not specified PATIENT CHARACTERISTICS: Age * 25 and over Sex * Female Menopausal status * Not specified Performance status * Not specified Life expectancy * Not specified Hematopoietic * No hemophilia * No other bleeding disorders Hepatic * Not specified Renal * Not specified Other * Not pregnant or nursing * At least 6 months postpartum * No planned pregnancy within the next year * No history of medical conditions that would increase participant risk of blood draws * No psychiatric, psychological, or other condition that would preclude giving informed consent PRIOR CONCURRENT THERAPY: Biologic therapy * Not specified Chemotherapy * Not specified Endocrine therapy * Not specified Radiotherapy * Not specified Surgery * No prior double mastectomy Other * No concurrent treatment for breast cancer
References
Publications (0)
Data not yet available
No reference posted for this study.